Company: MBIO
Filing Date: 2025-02-07
Form Type: 424B4
Source: 0001410578-25-000085
Chunk: 3

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-07
Form: 424B4
Chunk 3
---
 offering price of the securities we are offering and the exercise price and other terms of the Warrants include the history and prospects of our company, the stage of development of our business, our business plans for the future and the extent to which they have been implemented, an assessment of our management, general conditions of the securities markets at the time of the offering and such other factors as were deemed relevant. On January 15, 2025, we effected a reverse stock split of our common stock at a ratio of 1-for-50 reverse stock split. Unless otherwise indicated, all financial information, share numbers, option numbers, warrant numbers, other derivative security numbers and exercise prices appearing in this registration statement have been adjusted to give effect to the reverse stock split. We are a “smaller reporting company” as defined under the federal securities laws and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and may elect to comply with reduced public company reporting requirements in future filings. See “Prospectus Summary––Implications of Being a Smaller Reporting Company.” Additionally, we are a “controlled company” as defined under the Listing Rules of The Nasdaq Stock Market LLC (“Nasdaq”), because our existing controlling shareholder Fortress Biotech, Inc. is able to control a majority of the total voting power of our common stock. Investing in our securities involves risks. Before deciding whether to invest in our securities, you should consider carefully the risks that we have described on page 14 of this prospectus under the caption “Risk Factors.”

| ​                                   
 ​                                   |   | ​ 
 ​ |         Per Share and 
 Accompanying Warrants |   | ​ 
 ​ | Per Pre- Funded Warrant and 
       Accompanying Warrants |   | ​ 
 ​ |     Total |   |
|:------------------------------------|:--|:--|----------------------:|:--|:--|----------------------------:|:--|:--|----------:|:--|
| Public offering price               | ​ | $ |                  3.01 | ​ | $ |                      3.0099 | ​ | $ | 7,999,783 | ​ |
| Placement Agent’s fees (1)          | ​ | $ |                 0.211 | ​ | $ |                       0.211 | ​ | $ |   560,000 | ​ |
| Proceeds to us, before expenses (2) | ​ | $ |                 2.799 |